Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-28
2005-06-28
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S394000, C514S336000, C514S341000, C514S338000, C548S302700, C548S309700, C548S306100, C548S268400, C548S265800
Reexamination Certificate
active
06911462
ABSTRACT:
This invention relates to a family of phenylbenzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
REFERENCES:
patent: 6153631 (2000-11-01), Petrie et al.
patent: 6271390 (2001-08-01), Sircar et al.
patent: 6303645 (2001-10-01), Sircar et al.
patent: 6369091 (2002-04-01), Sircar et al.
patent: 6387938 (2002-05-01), Mizuguchi et al.
patent: 0 221 346 (1987-05-01), None
patent: 0 232 199 (1987-08-01), None
patent: 0 469 477 (1992-02-01), None
patent: 0 497 564 (1992-08-01), None
patent: 0 700 906 (1996-03-01), None
patent: 719765 (1996-03-01), None
patent: 0 719 765 (1996-07-01), None
patent: 98/17267 (1987-04-01), None
patent: 90/09989 (1990-09-01), None
patent: 93/25517 (1993-12-01), None
patent: WO 9961019 (1999-02-01), None
patent: WO 99 61020 (1999-02-01), None
patent: WO 8906975 (1999-08-01), None
patent: WO 0026192 (2000-05-01), None
patent: WO 0029384 (2000-05-01), None
Ashton et al., New Low-Density Lipoprotein Receptor Upregulators Acting via a Novel Mechanism, Journal of Medicinal Chemistry, vol. 39, Jan. 1, 1996, pp. 3343-3356.
Synthesis of 32-(Subtitutephenyl) Benzimidazole Derivatives and their Sedative Activity: Structure-activity Relationships, Journal Fac. Pharm. Gazi University, vol. 7, No. 2, 1990, pp. 111-124.
S. Kanag'ozov, Synthesis of N-acyl derivatives of 6-amino-1-4-benzodioxane STN International, vol. 39, No. 1989, pp. 5-8, Abstract only.
B.V. Cheney et al., Structure-activity Correlations for a Series of Antiallergy Agents. 3. Development of a Quantitative Model, Journal Med. Chem., vol. 26, No. 5, 1983, pp. 726-737.
Japanese Application No. 10273013, entitled Antagonist for Gonadotrophic Hormone-Releasing Hormone, filed on Sep. 28, 1996, English abstract only.
Database Crossifre Beilstein 'Onlinel, Beilstein Institut zur Forderung der Chemisehen Wissenchaften, Frankfurt am Main, DE; Beilstein Registry No. 563073 & Khim. Farm. ZH., vol. 22, No. 6, 1988, pp. 697-699, (english translation).
Denny W A et al., “Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of “minimal” DNA-intercalating agents which may not act via topolsomerase II”, Journal of Medicinal Chemistry, vol. 33, No. 2, Feb. 1990, pp. 814-819.
White A W et al., “Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase”, Journal of Medicinal Chemistry, vol. 43, No. 2, Nov. 2, 2000, pp. 4084-4097.
Database Caplus 'Onlinel Chemical Abstracts Service, Columbus, Ohio, US; Databse accession No. 2000:214835 & JP 2000 095767 (Takeda Chemical Industries, Ltd.), Apr. 4, 2000.
Kreimeyer A et al., “Suramin analogues with a 2-phenylbenzimidazole moiety as partyial structure; potential anti HIV- and anglostic drugs,2: Sulfanitic acid, benzendisulfonic, and naphthalanetrisulfonic acid analogues” Archi Der Pharmazie, vol. 331, No. 3, Mar. 1998, pp. 97-103.
Pozdnyakov et al. “Mass Spectrometric study of dissociative ionization of low-molecular models of aromatic polyamides” Khim. Vys. Energ. (1987), 21(1), 38-44 Coden: Khvkao; ISSN: 0023-1193, 1987.
Campbell Michael G.
Major Michael W.
Richards Mark L.
Sircar Jagadish C.
Avanir Pharmaceuticals
Kim Jennifer
Knobbe Martens Olson & Bear LLP
Padmanabhan Sreeni
LandOfFree
Benzimidazole compounds for regulating IgE does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole compounds for regulating IgE, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole compounds for regulating IgE will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3511034